SG Americas Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $819K | Sell |
|
|||||
|
2025
Q2 | $13.4M | Buy |
|
|||||
|
2025
Q1 | $6.59M | Buy |
|
|||||
|
2024
Q4 | $358K | Sell |
|
|||||
|
2024
Q3 | $441K | Sell |
|
|||||
|
2024
Q2 | $610K | Sell |
|
|||||
|
2024
Q1 | $3.1M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $439K | Sell |
|
|||||
|
2023
Q2 | $680K | Buy |
|
|||||
|
2023
Q1 | $285K | Sell |
|
|||||
|
2022
Q4 | $1.3M | Buy |
|
|||||
|
2022
Q3 | $145K | Sell |
|
|||||
|
2022
Q2 | $2.41M | Sell |
|
|||||
|
2022
Q1 | $5.2M | Buy |
|
|||||
|
2021
Q4 | $2.62M | Buy |
|
|||||
|
2021
Q3 | $120K | Sell |
|
|||||
|
2021
Q2 | $626K | Sell |
|
|||||
|
2021
Q1 | $869K | Sell |
|
|||||
|
2020
Q4 | $1.55M | Sell |
|
|||||
|
2020
Q3 | $4.68M | Sell |
|
|||||
|
2020
Q2 | $10.8M | Buy |
|
|||||
|
2020
Q1 | $940K | Sell |
|
|||||
|
2019
Q4 | $1.21M | Sell |
|
|||||
|
2019
Q3 | $6.57M | Buy |
|
|||||
|
2019
Q2 | $1.26M | Buy |
|
|||||
|
2019
Q1 | $1.23M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.72M | Buy |
|
|||||
|
2018
Q2 | $858K | Buy |
|
|||||
|
2018
Q1 | $631K | Buy |
|
|||||
|
2017
Q4 | $602K | Buy |
|
|||||
|
2017
Q3 | $148K | Sell |
|
|||||
|
2017
Q2 | $176K | Sell |
|
|||||
|
2017
Q1 | $2.12M | Sell |
|
|||||
|
2016
Q4 | $3.39M | Buy |
|
|||||
|
2016
Q3 | $1.29M | Sell |
|
|||||
|
2016
Q2 | $2.52M | Buy |
|
|||||
|
2016
Q1 | $2.11M | Sell |
|
|||||
|
2015
Q4 | $7.69M | Sell |
|
|||||
|
2015
Q3 | $5.97M | Buy |
|
|||||
|
2015
Q2 | $7.16M | Buy |
|
|||||
|
2015
Q1 | $5.96M | Sell |
|
|||||
|
2014
Q4 | $4.41M | Buy |
|
|||||
|
2014
Q3 | $1.78M | Buy |
|
|||||
|
2014
Q2 | $127K | Sell |
|
|||||
|
2014
Q1 | $1.18M | Buy |
|
|||||
|
2013
Q4 | $694K | Buy |
|
|||||
|
2013
Q3 | $683K | Buy |
|